These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14517928)

  • 1. Totally occluded saphenous vein graft recanalization: a dangerous option.
    Londero HF
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):218-20. PubMed ID: 14517928
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined distal embolization protection and rheolytic thrombectomy to facilitate percutaneous revascularization of totally occluded saphenous vein grafts.
    Gaitonde RS; Sharma N; von der Lohe E; Kalaria VG
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):212-7. PubMed ID: 14517927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous treatment of saphenous vein bypass graft obstructions: a continuing obstinate problem.
    de Feyter PJ
    Circulation; 2003 May; 107(18):2284-6. PubMed ID: 12742967
    [No Abstract]   [Full Text] [Related]  

  • 5. The unrelenting challenge of vein graft disease.
    Hermiller JB
    J Invasive Cardiol; 2010 Jun; 22(6):258-9. PubMed ID: 20516503
    [No Abstract]   [Full Text] [Related]  

  • 6. Contemporary management of vein graft disease.
    Hermiller J
    J Invasive Cardiol; 2005 Aug; 17(8):399-400. PubMed ID: 16079442
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical impact of atherosclerotic saphenous vein to coronary artery bypass grafts.
    Lytle BW
    Semin Thorac Cardiovasc Surg; 1994 Apr; 6(2):81-6. PubMed ID: 8025142
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal therapy for degenerated saphenous vein graft disease.
    Kramer B
    J Invasive Cardiol; 1995; 7 Suppl D():14D-20D. PubMed ID: 10155126
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
    Bansal D; Sachdeva R; Mehta JL
    J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
    [No Abstract]   [Full Text] [Related]  

  • 10. Embolic protection devices in saphenous percutaneous intervention.
    Morís C; Lozano I; Martín M; Rondán J; Avanzas P
    EuroIntervention; 2009 May; 5 Suppl D():D45-50. PubMed ID: 19736070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?
    Lozano I; Rondan J; Avanzas P
    Am Heart J; 2009 Sep; 158(3):e39; author reply e41. PubMed ID: 19699850
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrograde recanalization of native coronary artery chronic occlusions via acutely occluded vein grafts.
    Brilakis ES; Banerjee S; Lombardi WL
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):109-13. PubMed ID: 19670306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheolytic thrombectomy with distal filter embolic protection as adjunctive therapies to high-risk saphenous vein graft intervention.
    Ho PC; Leung CY
    Catheter Cardiovasc Interv; 2004 Feb; 61(2):202-5. PubMed ID: 14755812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary angioplasty and new devices in patients with prior coronary artery bypass graft surgery.
    Ribeiro PA
    Rev Port Cardiol; 1999 Feb; 18 Suppl 1():I105-11. PubMed ID: 10191682
    [No Abstract]   [Full Text] [Related]  

  • 15. Approach to the patient with prior bypass surgery.
    Nguyen T; Pham L; Cheem TH; Douglas JS; Hermiller J; Grines C
    J Interv Cardiol; 2004 Oct; 17(5):339-46. PubMed ID: 15491339
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment alternatives for chronically occluded saphenous vein grafts.
    Heuser RR
    J Invasive Cardiol; 1995 May; 7(4):94-6. PubMed ID: 10158110
    [No Abstract]   [Full Text] [Related]  

  • 17. Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic?
    Fiorina C; Meliga E; Chizzola G; Curello S; Tayeh O; Vizzardi E; Dei Cas L; Ettori F
    EuroIntervention; 2010 Sep; 6(4):461-6. PubMed ID: 20884433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DES in saphenous bypass grafts: A treatment in vain?
    Hillegass WB
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):21-2. PubMed ID: 18561144
    [No Abstract]   [Full Text] [Related]  

  • 19. PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.
    Reifart N; Störger H; Schwarz F; Rabe A
    Indian Heart J; 1998 Oct; 50 Suppl 1():62-6. PubMed ID: 9824909
    [No Abstract]   [Full Text] [Related]  

  • 20. Stenting for saphenous vein graft disease: have we solved the problem?
    Chauhan MS; Carrozza JP
    J Invasive Cardiol; 2000 Oct; 12(10):513-5. PubMed ID: 11022210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.